Commonwealth Equity Services LLC reduced its Omega Healthcare Investors stake by 8.1% during the third quarter, divesting 26,638 shares and ending the period with 302,997 shares valued at approximately 12.8 million dollars. This adjustment reflects a shift in asset allocation by a firm that previously held about 0.10% of the REIT. Alongside Commonwealth’s move, several smaller managers—such as Smartleaf Asset Management, CENTRAL TRUST Co, and Bayforest Capital—expanded their positions by between 40.9% and 1,654.4%, while new stakes were established by Caitong International Asset Management and Salem Investment Counselors. Hedge funds and other institutions collectively control roughly 65.3% of the outstanding shares, underscoring the importance of institutional flows for OHI’s share supply and demand dynamics.

In its latest quarterly report, Omega Healthcare Investors delivered funds from operations of 0.79 per share, exceeding the consensus by 2 cents, on revenues of 311.6 million dollars, up 14.4% from the prior year and topping estimates by nearly 49 million. The REIT reported a return on equity of 10.7% and a net margin of 46.8%. Management reiterated its full-year guidance at 3.08 to 3.10 in FFO per share, aligning with analyst projections around 2.86. These metrics, coupled with a debt-to-equity ratio near 1.0 and strong liquidity—evidenced by current and quick ratios above 7.0—support OHI’s capacity to sustain its distribution policy and pursue disciplined acquisitions in the long-term care sector.

During early November, CEO C. Taylor Pickett acquired 20,000 shares at an average cost in the low 40s per share, increasing his holdings to that same level, while CIO Vikas Gupta added 11,500 shares, boosting his stake by more than 500%. Insider ownership now stands at approximately 1.5%, signaling executive confidence in the business model. On the sell-side, one analyst has assigned a Strong Buy rating, six maintain Buy recommendations and seven favor Hold, resulting in a consensus Moderate Buy stance with an average target near 47.09. Recent upgrades by UBS and reaffirmations from Citigroup underscore expectations for continued growth in distributions and portfolio cash flow generation.